Results 211 to 220 of about 195,691 (306)

Enhancing adherence to guideline-directed use of anticoagulant therapy in atrial fibrillation: a triad of quality improvement interventions in an academic outpatient setting. [PDF]

BMJ Open Qual
Xiang K, Ndai AM, Reise R, Rosenberg EI, Catanzaro JN, Smith AM, Moore M, Singer T, Tamas M, Jackson M, Dietrich E, Conti J, Dewar M.   +12 more
europepmc   +1 more source

Oral anticoagulant therapy.

, 1995
松田 保
openalex   +2 more sources

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Optimal Timing of Oral Anticoagulant Therapy Initiation Post-acute Ischemic Stroke: A Narrative Review. [PDF]

Cureus
Aderinto N, Aljamea LH, Aljamea FH.
europepmc   +1 more source

Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data

А. И. Листратов, I. I. Ivanov, Nadezhda K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, Д. А. Напалков, А. А. Соколова   +8 more
openalex   +2 more sources

Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. [PDF]

, 1989
Belle, S., Esquivel, C.O., Ferla, G., Kahn, D., Kahn, D., Koneru, B., Makowka, L., Mazzaferro, V., Scantlebury, V.P., Scotti-Foglieni, C.L., Starzl, T.E., Todo, S., Tzakis, A.G.   +12 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Development of an Electrochemical Immunosensor for Detecting Coagulation Factor Xa and Perspectives in Monitoring Direct Oral Anticoagulant Therapy. [PDF]

ACS Omega
Meireles MR, Moreira JK, Dalpiaz G, Krohn MS, Jantzch GVM, Hasenkamp Carreira W.   +5 more
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Improving Safe Initiation of Direct Oral Anticoagulant Therapy: A Two-Cycle Quality Improvement Project. [PDF]

Cureus
Shrestha O, Joshi H, San S, Richards J.
europepmc   +1 more source